BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025
Rhea-AI Summary
BiomX (NYSE American: PHGE) will report third quarter 2025 financial results and program updates before U.S. market open on Wednesday, November 12, 2025. The company will host a conference call and live audio webcast at 8:30 AM ET to discuss results and program progress.
Registration is recommended at least 5 minutes before the call; the webcast will be live and archived on the company website.
Positive
- None.
Negative
- None.
News Market Reaction 4 Alerts
On the day this news was published, PHGE gained 1.97%, reflecting a mild positive market reaction. Argus tracked a peak move of +10.7% during that session. Argus tracked a trough of -12.8% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $206K to the company's valuation, bringing the market cap to $11M at that time.
Data tracked by StockTitan Argus on the day of publication.
NESS ZIONA, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it will report its third quarter 2025 financial results and program updates before the open of the U.S. financial markets on Wednesday, November 12, 2025. The Company will host a conference call and a live audio webcast at 8:30 a.m. ET, to discuss the third quarter of 2025 financial results and provide program updates.
To ensure you are connected prior to the beginning of the call, BiomX suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the webcast.
Conference Call Dial-In & Webcast Information:
| Date: | Wenesday, November 12, 2025 |
| Time: | 8:30 AM Eastern Time |
| Conference Call | https://register-conf.media-server.com/register/BIf7434533b852452a822a8e5f48b669e2 |
| Webcast: | https://edge.media-server.com/mmc/p/s6tntmgo |
The live and archived webcast will also be available in the Investors section of the Company’s website at www.biomx.com.
About BiomX
BiomX is a clinical-stage company leading the development of natural and engineered phage cocktails and personalized phage treatments designed to target and destroy harmful bacteria for the treatment of chronic diseases with substantial unmet needs. BiomX discovers and validates proprietary bacterial targets and applies its BOLT (“BacteriOphage Lead to Treatment”) platform to customize phage compositions against these targets. For more information, please visit www.biomx.com, the content of which does not form a part of this press release.
Contacts:
BiomX, Inc.
Ben Cohen
Head Corporate Communications
benc@biomx.com
FAQ
When will BiomX (PHGE) report third quarter 2025 results?
What time is the BiomX (PHGE) Q3 2025 conference call and webcast?
How can investors join the BiomX (PHGE) November 12, 2025 webcast?
Is registration required for the BiomX (PHGE) November 12, 2025 call?
Where will the archived BiomX (PHGE) Q3 2025 webcast be available?
